يعرض 1 - 10 نتائج من 355 نتيجة بحث عن '"BLOIGU, AINI"', وقت الاستعلام: 1.78s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    دورية أكاديمية

    المساهمون: Tampere University, Clinical Medicine, Seinäjoen keskussairaala VA, Department of Child Psychiatry

    مصطلحات موضوعية: 3124 Neurology and psychiatry

    وصف الملف: fulltext

    العلاقة: 4529; 21; 14; https://trepo.tuni.fi/handle/10024/143948Test; URN:NBN:fi:tuni-202212028816

  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المساهمون: HUS Gynecology and Obstetrics, Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital Area, Clinicum

    وصف الملف: application/pdf

    العلاقة: This study was funded by research funds from the Hospital District of Helsinki and Uusimaa, Finland.; Kemppainen , V , Niinimäki , M , Bloigu , A , Saisto , T , Rouhe , H , Gissler , M , Heikinheimo , O & Mentula , M 2021 , ' Fear of childbirth after medical versus surgical abortion. Population-based register study from Finland ' , Acta Obstetricia et Gynecologica Scandinavica , vol. 100 , no. 4 , pp. 743-750 . https://doi.org/10.1111/aogs.14078Test; 836aa1a9-3023-4e30-a4ee-a5b7b923ed6a; http://hdl.handle.net/10138/340004Test; 000610459600001

  8. 8
    دورية أكاديمية

    المساهمون: Institute for Molecular Medicine Finland, University of Helsinki, HUS Helsinki and Uusimaa Hospital District, Clinicum, Biostatistics Helsinki, Faculty of Medicine, Helsinki University Hospital Area, Centre of Excellence in Complex Disease Genetics, HUS Abdominal Center, University Management, Department of Public Health, Samuli Olli Ripatti / Principal Investigator, Complex Disease Genetics, Research Programs Unit, Department of Medicine, Endokrinologian yksikkö

    وصف الملف: application/pdf

    العلاقة: V.A. was funded through a grant from the Academy of Finland (grant 312072). The Botnia studies (L.G., T.T.) have been financially supported by grants from Folkhalsan Research Foundation, the Sigrid Juselius Foundation, the Academy of Finland (grants 263401, 267882, 312063 to L.G. and 312072 to T.T.), University of Helsinki, Nordic Center of Excellence in Disease Genetics, the European Union (EXGENESIS and MOSAIC projects, FP7-600914), Ollqvist Foundation, Swedish Cultural Foundation in Finland, Finnish Diabetes Research Foundation, Foundation for Life and Health in Finland, Signe and Ane Gyllenberg Foundation, Finnish Medical Society, Paavo Nurmi Foundation, State Research Funding via the Helsinki University Hospital, Perklen Foundation, Narpes Health Care Foundation, and Ahokas Foundation. The study has also been supported by the Ministry of Education in Finland, Municipal Health Care Center and Hospital in Jakobstad, and Health Care Centers in Vasa, Narpes, and Korsholm. The Botnia Study has received research funding from Pfizer Inc. and Regeneron Pharmaceuticals. The research leading to these results received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 269045. T.V.F. was supported by the European Foundation for the Study of Diabetes. DIAPASON (Diabetes Prediction and Screening Observational) was supported by Fondazione Romeo ad Enrica Invernizzi-Milano, an EFSD/Sanofi program (to L.L.S.), and Italian Ministry of Health-Ricerca Corrente. GENFIEV has been supported by FoRiSID, Rome, Italy, and an unconditional grant from Eli Lilly, Italy. GOH (Israel Study of Glucose Intolerance, Obesity and Hypertension) was funded by The DCURE Foundation. Oulu45 and Oulu45P studies were funded by the Finnish Cultural Foundation Central Fund. PIBS (Pima Indian Biennial Study) was funded by the Division of Intramural Research of National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The PSW (Public School Worker) and PSWP (Public School Worker Prospective) studies were funded by the Japan Health Promotion Foundation and Grant-in-Aid from Toyama Medical Association. A.Ce. receives research support from Mitsubishi; is amemberof the advisory boards of Abbott, BDBiosciences, Eli Lilly, Janssen, and Mundipharma; and is a member of the speakers bureaus of AstraZeneca, Berlin Chemie, Boehringer Ingelheim, Novo Nordisk, and Roche Diagnostics. C.B. receives honoraria for consulting from Novo Nordisk and research support from Roche Diagnostics. J.T. received research grants from Bayer Pharma, Boehringer Ingelheim, Merck, andSanofi; received consulting and travel fees from Eli Lilly, Merck, Merck Sharp & Dohme, and Novo Nordisk; and owns stocks of Orion Pharma. No other potential conflicts of interest relevant to this article were reported.; Ahuja , V , Aronen , P , Pramodkumar , T A , Looker , H , Chetrit , A , Bloigu , A H , Juutilainen , A , Bianchi , C , La Sala , L , Anjana , R M , Pradeepa , R , Venkatesan , U , Jebarani , S , Baskar , V , Fiorentino , T V , Timpel , P , DeFronzo , R A , Ceriello , A , Del Prato , S , Abdul-Ghani , M , Keinanen-Kiukaanniemi , S , Dankner , R , Bennett , P H , Knowler , W C , Schwarz , P , Sesti , G , Oka , R , Mohan , V , Groop , L , Tuomilehto , J , Ripatti , S , Bergman , M & Tuomi , T 2021 , ' Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults : A Meta-analysis ' , Diabetes Care , vol. 44 , no. 4 , pp. 1062-1069 . https://doi.org/10.2337/dc20-1688Test; ORCID: /0000-0002-8306-6202/work/93675442; badffc76-7cfb-4891-98e6-b1023e912d53; http://hdl.handle.net/10138/339867Test; 000630755000037

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية